Programme
09:00-09:30 h.
Inauguration
Dr. Ángel Carracedo. Director of Genomic medicine foundation
Dra. Angélica Figueroa. Principal Investigator of INIBIC
09:30-11:30 h.
Sesion I – innovation: drug discovery and development in cancer
CHAIR:
Dra. Mabel Loza. Professor of pharmacology at USC, scientific director and founder in Kaertor Foundation
→ 09:30-09:50 h.
Dra. Laura Soucek. Principal Investigator of VHIO´s Models of Cancer Therapies Group. ICREA Research Professor. Co-founder & CEO at PEPTOMYC S.L
THE JOURNEY OF A FIRST-IN-CLASS MYC INHIBITOR FROM BENCH TO CLINICAL TRIAL
→ 10:00-10:20 h.
Dr. Salvador A. Benitah. ICREA Senior Group Leader at IRB, Co-founder & CSO at ONA Therapeutics
EPIGENETIC CONSEQUENCES OF OUR (FATTY) DIET IN METASTASIS: ROLE OF SCHWANN CELLS
→ 10:30-10:50 h.
Dr. Héctor G. Palmer. Principal Investigator of VHIO´s Stem Cells and Cancer Group. Co-founder & CSO at Oniria Therapeutics
To be confirmed
→ 11:00-11:20 h.
Dra. Angélica Figueroa. Principal Investigator of INIBIC. Epithelial Plasticity and Metastasis Group
TARGETING PROTEIN DEGRADATION AGAINST CANCER
11:30-12:00 h.
BREAK AND POSTER SESSION
12:00-14:00 h.
Sesion II – CANCER RESEARCH WITH CLINICAL IMPACT
CHAIR:
Dr. Xose Bustelo. Full Professor at CSIC. Cancer Research Center-Salamanca University
→ 12:00-12:20 h.
Dr. Manuel Valiente. Principal investigator Brain Metastasis Group at CNIO
STRATEGIES TO CHALLENGE BRAIN METASTASIS LETHALITY IN MICE AND HUMAN
→ 12:30-12:50 h.
Dr. Javier de las Rivas. Principal Investigator at CSIC, Bioinformatics and Functional Genomics. Cancer Research Center Salamanca University
DISCOVERY OF GENE MARKERS ASSOCIATED WITH SURVIVAL AND RISK IN COLORECTAL CANCER (CRC) AND BREAST CANCER (BRCC)
→ 13:00-13:20 h.
Dr. Víctor Moreno. Director Clinical Research Phase 1 Trials Unit. START Madrid-FJD, Hospital Fundación Jiménez Díaz
CELLULAR THERAPY FOR SOLID TUMOURS
→ 13:30-14:00 h.
Dra. Sonia Zumalave. PhD candidate at Mobile Genomes Lab (CiMUS, University of Santiago de Compostela).
THE IMPACT OF SOMATIC RETROTRANSPOSON ACTIVITY IN THE ORIGIN AND DEVELOPMENT OF HUMAN CANCER
14:00-15:00 h.
BREAK
15:00-16:30 h.
Sesion IV – Young Researchers
CHAIR:
Dra. Esperanza Cerdán. Full Professor at Universidade da Coruña (UDC) / Advanced Scientific Research Center (CICA)
15:00-16:00 h.
Selected Short talks from received communications
16:30 h.
Award and closure
Dra. Angélica Figueroa. Principal Investigator of INIBIC
Dra. Esperanza Cerdán. Full Professor at Universidade da Coruña (UDC) / Advanced Scientific Research Center (CICA)